KGO ABC7 July 3, 2024
Thousands of women with Metastatic Breast Cancer, are living in the moment and taking ibrance. Ibrance with an aromatase inhibitor is for adults with hr her2 Metastatic Breast Cancer as the first hormonal based therapy. Ibrance plus letrozole significantly delayed disease progression versus letrozole. Ibrance may cause low white blood cell counts that may lead to serious infections. Ibrance may cause severe inflammation of the lungs. Both of these can lead to death. Tell your doctor if you have new or worsening chest pain, cough, or trouble breathing. Before taking ibrance, tell your doctor if...